Sujaya Srinivasan from 19 Dickens Dr, W Windsor Township, NJ 08550, age 50

Resumes

Genomics And Healthcare Solutions Architect, Academic Medical Centers

view source

Location:

19 Dickens Dr west, Windsor, NJ

Industry:

Biotechnology

Work:

Amazon Web Services
Genomics and Healthcare Solutions Architect, Academic Medical Centers
Bristol-Myers Squibb
Senior Research Scientist
Strand Life Sciences Jun 1, 2013 - Apr 2016
Senior Applications Scientist
Medeolinx Sep 2012 - Apr 2013
Bioinformatics Scientist
Indian Institute of Science Jun 1, 2010 - Sep 1, 2012
Senior Research Fellow

Education:

The Johns Hopkins University
Master of Science, Masters, Bioinformatics University of Maryland
Master of Science, Masters, Computer Engineering Pg Center, Kolar
Bachelor of Engineering, Bachelors, Communication, Electronics

Skills:

Bioinformatics
Genomics
Molecular Biology
Genetics
Life Sciences
Cancer
Data Analysis
Cell
Computational Biology
Dna Sequencing
Microarray Analysis
Sequence Analysis
Nextgen
Personalized Medicine
Cancer Genomics
Ngs
Molecular Oncology
Amazon Web Services
R
Python
Perl
Biostatistics

Interests:

Science and Technology
Environment
Education
Children

Languages:

English
Tamil
Kannada
Hindi

Sujaya Srinivasan

view source

Us Patents

Methods Of Treating Tumor
view source
US Patent:

20220195046, Jun 23, 2022
Filed:

Mar 27, 2020
Appl. No.:

17/599433
Inventors:

- Princeton NJ, US
Nathan O. SIEMERS - Pacific Grove CA, US
Dimple PANDYA - Princeton NJ, US
Han CHANG - West Windsor NJ, US
Teresa K. SANCHEZ - Princeton NJ, US
Christopher T. HARBISON - Hamilton NJ, US
Peter M. SZABO - Pennington NJ, US
Zachary S. BOYD - Skillman NJ, US
Xiaozhong QIAN - Pennington NJ, US
Samy Abdel SACI - Lawrenceville NJ, US
Tina C. YOUNG - Lawrence Township NJ, US
Sujaya SRINIVASAN - Princeton Junction NJ, US
Megan M. WIND-ROTOLO - Newtown PA, US
Jasmine RIZZO - Edison NJ, US
Donald G. JACKSON - Hopkinton MA, US
Alice M. WALSH - Glenside PA, US
Assignee:

Bristol-Myers Squibb Company - Princeton NJ
International Classification:

C07K 16/28
A61P 35/00
Abstract:

The disclosure provides a method for treating a subject afflicted with a tumor comprising administering to the subject a therapeutically effective amount of an anti-PD-1 antibody or antigen-binding portion thereof or an anti-PD-L1 antibody or anti-gen-binding portion thereof, wherein the subject is identified as having a high inflammatory gene signature score and a tumor that has a high tumor mutation burden (TMB) status. In some embodiments, the high inflammatory gene signature score is determined by measuring the expression of a panel of inflammatory genes in a tumor sample obtained from the subject, wherein the inflammatory gene panel comprises CD274 (PD-L1), CD8A, LAG3, and STAT1.